219 related articles for article (PubMed ID: 9926830)
1. Quinpirole induces compulsive checking behavior in rats: a potential animal model of obsessive-compulsive disorder (OCD).
Szechtman H; Sulis W; Eilam D
Behav Neurosci; 1998 Dec; 112(6):1475-85. PubMed ID: 9926830
[TBL] [Abstract][Full Text] [Related]
2. Development and temporal organization of compulsive checking induced by repeated injections of the dopamine agonist quinpirole in an animal model of obsessive-compulsive disorder.
Dvorkin A; Perreault ML; Szechtman H
Behav Brain Res; 2006 May; 169(2):303-11. PubMed ID: 16524632
[TBL] [Abstract][Full Text] [Related]
3. Role of dopamine systems in obsessive-compulsive disorder (OCD): implications from a novel psychostimulant-induced animal model.
Szechtman H; Culver K; Eilam D
Pol J Pharmacol; 1999; 51(1):55-61. PubMed ID: 10389145
[TBL] [Abstract][Full Text] [Related]
4. Kappa-opioid receptor stimulation quickens pathogenesis of compulsive checking in the quinpirole sensitization model of obsessive-compulsive disorder (OCD).
Perreault ML; Seeman P; Szechtman H
Behav Neurosci; 2007 Oct; 121(5):976-91. PubMed ID: 17907829
[TBL] [Abstract][Full Text] [Related]
5. Effect of nicotine on quinpirole-induced checking behavior in rats: implications for obsessive-compulsive disorder.
Tizabi Y; Louis VA; Taylor CT; Waxman D; Culver KE; Szechtman H
Biol Psychiatry; 2002 Jan; 51(2):164-71. PubMed ID: 11822995
[TBL] [Abstract][Full Text] [Related]
6. Changes in gut microbiota during development of compulsive checking and locomotor sensitization induced by chronic treatment with the dopamine agonist quinpirole.
Jung TD; Jung PS; Raveendran L; Farbod Y; Dvorkin-Gheva A; Sakic B; Surette MG; Szechtman H
Behav Pharmacol; 2018 Apr; 29(2 and 3-Spec Issue):211-224. PubMed ID: 29194070
[TBL] [Abstract][Full Text] [Related]
7. Psychostimulant-induced behavior as an animal model of obsessive-compulsive disorder: an ethological approach to the form of compulsive rituals.
Eilam D; Szechtman H
CNS Spectr; 2005 Mar; 10(3):191-202. PubMed ID: 15744221
[TBL] [Abstract][Full Text] [Related]
8. Modulation of quinpirole-induced compulsive-like behavior in rats by environmental changes: implications for OCD rituals and for exploration and navigation.
Zadicario P; Ronen S; Eilam D
BMC Neurosci; 2007 Mar; 8():23. PubMed ID: 17386094
[TBL] [Abstract][Full Text] [Related]
9. Detrimental effect of clomipramine on hippocampus-dependent learning in an animal model of obsessive-compulsive disorder induced by sensitization with d2/d3 agonist quinpirole.
Hatalova H; Radostova D; Pistikova A; Vales K; Stuchlik A
Behav Brain Res; 2017 Jan; 317():210-217. PubMed ID: 27659555
[TBL] [Abstract][Full Text] [Related]
10. Compulsive checking behavior of quinpirole-sensitized rats as an animal model of Obsessive-Compulsive Disorder(OCD): form and control.
Szechtman H; Eckert MJ; Tse WS; Boersma JT; Bonura CA; McClelland JZ; Culver KE; Eilam D
BMC Neurosci; 2001; 2():4. PubMed ID: 11316464
[TBL] [Abstract][Full Text] [Related]
11. 5-HT2A/C receptors do not mediate the attenuation of compulsive checking by mCPP in the quinpirole sensitization rat model of obsessive-compulsive disorder (OCD).
Tucci MC; Dvorkin-Gheva A; Johnson E; Wong M; Szechtman H
Behav Brain Res; 2015 Feb; 279():211-7. PubMed ID: 25449840
[TBL] [Abstract][Full Text] [Related]
12. Quinpirole and 8-OH-DPAT induce compulsive checking behavior in male rats by acting on different functional parts of an OCD neurocircuit.
Alkhatib AH; Dvorkin-Gheva A; Szechtman H
Behav Pharmacol; 2013 Feb; 24(1):65-73. PubMed ID: 23249525
[TBL] [Abstract][Full Text] [Related]
13. Separate mechanisms for development and performance of compulsive checking in the quinpirole sensitization rat model of obsessive-compulsive disorder (OCD).
Tucci MC; Dvorkin-Gheva A; Sharma R; Taji L; Cheon P; Peel J; Kirk A; Szechtman H
Psychopharmacology (Berl); 2014 Sep; 231(18):3707-18. PubMed ID: 24682503
[TBL] [Abstract][Full Text] [Related]
14. Structural and functional MRI of altered brain development in a novel adolescent rat model of quinpirole-induced compulsive checking behavior.
Straathof M; Blezer ELA; van Heijningen C; Smeele CE; van der Toorn A; ; Buitelaar JK; Glennon JC; Otte WM; Dijkhuizen RM
Eur Neuropsychopharmacol; 2020 Apr; 33():58-70. PubMed ID: 32151497
[TBL] [Abstract][Full Text] [Related]
15. Effects of the serotonergic agonist mCPP on male rats in the quinpirole sensitization model of obsessive-compulsive disorder (OCD).
Tucci MC; Dvorkin-Gheva A; Graham D; Amodeo S; Cheon P; Kirk A; Peel J; Taji L; Szechtman H
Psychopharmacology (Berl); 2013 May; 227(2):277-85. PubMed ID: 23354534
[TBL] [Abstract][Full Text] [Related]
16. Effects of hypophysectomy on compulsive checking and cortical dendrites in an animal model of obsessive-compulsive disorder.
Dvorkin A; Culver KE; Waxman D; Szechtman H; Kolb B
Behav Pharmacol; 2008 Jul; 19(4):271-83. PubMed ID: 18622174
[TBL] [Abstract][Full Text] [Related]
17. Memantine treatment does not affect compulsive behavior or frontostriatal connectivity in an adolescent rat model for quinpirole-induced compulsive checking behavior.
Straathof M; Blezer ELA; Smeele CE; van Heijningen C; van der Toorn A; Buitelaar JK; Glennon JC; Otte WM; Dijkhuizen RM;
Psychopharmacology (Berl); 2022 Aug; 239(8):2457-2470. PubMed ID: 35419637
[TBL] [Abstract][Full Text] [Related]
18. Behavioral pattern analysis and dopamine release in quinpirole-induced repetitive behavior in rats.
de Haas R; Nijdam A; Westra TA; Kas MJ; Westenberg HG
J Psychopharmacol; 2011 Dec; 25(12):1712-9. PubMed ID: 21148023
[TBL] [Abstract][Full Text] [Related]
19. Dissociable dopaminergic and pavlovian influences in goal-trackers and sign-trackers on a model of compulsive checking in OCD.
Eagle DM; Schepisi C; Chugh S; Desai S; Han SYS; Huang T; Lee JJ; Sobala C; Ye W; Milton AL; Robbins TW
Psychopharmacology (Berl); 2020 Dec; 237(12):3569-3581. PubMed ID: 32886158
[TBL] [Abstract][Full Text] [Related]
20. Marked inbred mouse strain difference in the expression of quinpirole induced compulsive like behavior based on behavioral pattern analysis.
de Haas R; Seddik A; Oppelaar H; Westenberg HG; Kas MJ
Eur Neuropsychopharmacol; 2012 Sep; 22(9):657-63. PubMed ID: 22326620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
